CD4 and cryptococcosis: Our study provides the first evidence for the diagnostic performance of the CrAgSQ in a CrAg screening program targeting individuals with CD4 cell counts of ≤200 cells/μl, and it also provides information to guide the interpretation of CrAgSQ scores in HIV-infected patients with cryptococcal infection.